Boobalan Pachaiyappan
Stock Analyst at Roth Capital
(0.68)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VRNA Verona Pharma | Reiterates: Strong Buy | 92 116 | 93.84 | 23.61% | 2 | Jun 18, 2025 | |
PYPD PolyPid | Maintains: Buy | 12 9 | 3.57 | 152.1% | 2 | Jun 18, 2025 | |
CAPR Capricor Therapeutic... | Reiterates: Buy | 31 31 | 11.16 | 177.78% | 1 | Jun 17, 2025 | |
CING Cingulate | Maintains: Buy | 12 11 | 4.04 | 172.28% | 2 | May 19, 2025 | |
CRVO CervoMed | Maintains: Strong Buy | 15 20 | 6.24 | 220.51% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 7 | n/a | n/a | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 7 7 | 1.96 | 257.14% | 2 | Dec 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 29 | 6.9 | 320.29% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 10 | 1.34 | 646.27% | 1 | Dec 5, 2024 |